Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

606 evidences · page 8 / 25

15,1 %The risk of recurrent parasitaemia was 15.1% in the group given artemether-lumefantrine.

Burkina Fasopaludismepublié 2007Lancet (London, England)europe_pmcdocument de 5 observations

1,28 relative_riskThe relative risk of malaria in primigravidae compared to nulliparae was 1.28.

Burkina Fasopaludismepublié 2020Clinical nutrition (Edinburgh, Scotland)europe_pmcdocument de 7 observationsDOI 10.1016/j.clnu.2019.01.016

0 %Malaria prevalence among febrile adults from non-malaria endemic countries travelling or living in Burkina Faso was 0% for journeys over 3 months with adapted and well-taken chemoprophylaxis.

Burkina FasopaludismeHAL · Unilimdocument de 83 observations

96,1 %96.1% of enrolled patients met protocol requirements for analysis in an observational study on dihydroartemisinin-piperaquine for uncomplicated malaria in Burkina Faso, Ghana, Mozambique, and Tanzania between September 2013 and April 2014.

Burkina Faso · Ghana · Mozambique · Tanzaniepaludismeobservé September 2013 to April 2014publié 2016Malaria journaleurope_pmcdocument de 6 observations

1,8 %Au Burkina Faso, l'examen microscopique a détecté une prévalence de 1,8 % d'infections à P. ovale dans une population de 830 enfants âgés de trois à quinze ans.

Burkina FasopaludismeHAL · Unilimdocument de 80 observations

9,95 %In the 6 months-4 years age group, Plasmodium falciparum prevalence assessed using microscopy was 9.95% in Bagamoyo, Tanzania.

Burkina Fasopaludismepublié 2017Malaria journaleurope_pmcdocument de 16 observations

10 daysIn the laboratory, mosquitoes fed with papaya juices lived on average longer (10 days) than those fed with banana or mango juices (5 days).

Burkina Fasopaludismepublié 2020Malaria journaleurope_pmcdocument de 4 observations

20 titerAfter three vaccinations, the PfCSP-specific geometric mean titer (GMT) increased to 20.0 at day 70 in the ProC6C-AlOH group.

Burkina Fasopaludismeobservé D70HAL · Unilimdocument de 39 observations

35,1 %In Orodara, the endophagy rate of An. gambiae s.l. increased from 35.1% (95% CI 32.0–38.2) in year 1 to 42.8% (95% CI 38.8–46.8) in year 2, and to 45.1% (95% CI 41.5–48.7) in year 3.

Burkina FasopaludismeHAL · Unilimdocument de 87 observations

Aucun impact de l’intervention communautaire n’a été noté sur l’incidence cumulée du paludisme chez la femme enceinte au Burkina Faso et au Mali.

Burkina Faso · MalipaludismeHAL · Unilimdocument de 302 observations

19 %The proportion of chloroquine-resistant Plasmodium falciparum isolates was 19% in 1996 in the region of Bobo-Dioulasso.

Burkina Fasopaludismeobservé 1996publié 1998Tropical medicine & international health : TM & IHeurope_pmcdocument de 4 observations

85 %In the rainy season, 85.0% and 82.6% of patients with a negative RDT were nevertheless diagnosed and treated for malaria.

Burkina Fasopaludismeobservé rainy seasonpublié 2009Tropical medicine & international health : TM & IHeurope_pmcdocument de 4 observationsDOI 10.1111/j.1365-3156.2009.02246.x

89,52 %In the town of Koudougou, 89.52% of households living more than 500 metres from a water body have a low risk of malaria contamination.

Burkina FasopaludismeHAL · Unilimdocument de 110 observations

6,5 mg/kgBody iron was higher in primigravidae with malaria (6.5 mg/kg) than in those without malaria (5.0 mg/kg).

Burkina Fasopaludismepublié 2020Clinical nutrition (Edinburgh, Scotland)europe_pmcdocument de 7 observationsDOI 10.1016/j.clnu.2019.01.016

82 %The Pfcrt T76 mutation was found in 82% of the samples having the Pfmdr-1 Y86 mutation in Plasmodium falciparum isolates from patients with uncomplicated malaria in Burkina Faso.

Burkina Fasopaludismepublié 2003Infection, genetics and evolution : journal of molecular epidemiology and evolutionary geneurope_pmcdocument de 4 observations

4,2 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 4.2% showed a 10-fold increase in anti-CSP IgG antibody titres post-2021 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobservé post-2021HAL · Unilimdocument de 105 observations

98,5 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 98.5% showed a 2-fold increase in anti-CSP IgG antibody titres post-2017 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobservé post-2017HAL · Unilimdocument de 105 observations

94 %Seven days post-infection, mortality for insecticide-sensitive and resistant mosquitoes averaged 94% with Met-Hybrid.

Burkina Fasopaludismepublié 2018PloS oneeurope_pmcdocument de 5 observations

41,8 %Malaria prevalence was 41.8% in nulliparae.

Burkina Fasopaludismepublié 2020Clinical nutrition (Edinburgh, Scotland)europe_pmcdocument de 7 observationsDOI 10.1016/j.clnu.2019.01.016

75 %The major NANP repeat accounted for approximately 75% of the anti-CSP IgG at D70 (14 days after 3rd vaccination) in Burkinabé adults vaccinated with ProC6C-AlOH/Matrix-M.

Burkina Fasopaludismeobservé D70HAL · Unilimdocument de 39 observations

39 %La prévalence de l'infection à Plasmodium falciparum était de 39 % (538/1367) dans le groupe LLIN plus IRS au Burkina Faso avant intervention.

Burkina FasopaludismeHAL · Unilimdocument de 85 observations

37 %La prévalence de l'infection à Plasmodium falciparum était de 37 % (616/1670) dans le groupe LLIN plus IRS au Burkina Faso après intervention.

Burkina FasopaludismeHAL · Unilimdocument de 85 observations

20 titerAfter three vaccinations, the PfCSP-specific geometric mean titer (GMT) increased to 20.0 at day 70 in the group receiving 100 μg ProC6C-AlOH (G2C).

Burkina Fasopaludismeobservé D70HAL · Unilimdocument de 39 observations

50 %The purified and pooled IgG from human volunteers, used in a passive transfer mouse sporozoite challenge model, showed a median of 50% inhibition.

Burkina FasopaludismeHAL · Unilimdocument de 39 observations

1 caseOnly one case of Plasmodium vivax was detected from Sao Tome.

Burkina Fasopaludismepublié 2008Malaria journaleurope_pmcdocument de 5 observationsDOI 10.1186/1475-2875-7-174

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.